US 10736894
Methods of treating developmental syndromes with PDE10A inhibitors
granted A61KA61K31/4709A61K31/497
Quick answer
US patent 10736894 (Methods of treating developmental syndromes with PDE10A inhibitors) held by OVID THERAPEUTICS INC. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4709, A61K31/497, A61K31/501, A61P